APO Research

APO RESEARCH · REPORT

Ceritinib Capsules

Selected research

Market Analysis & Forecast

Global Ceritinib Capsules Market Analysis and Forecast 2026-2032

Market perspective

The global Ceritinib Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ceritinib Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ceritinib Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ceritinib Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ceritinib Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ceritinib Capsules include Novartis and Jiangsu Aosaikang Pharmaceutical etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ceritinib Capsules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ceritinib Capsules, also provides the sales of main regions and countries. Of the upcoming market potential for Ceritinib Capsules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ceritinib Capsules sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ceritinib Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ceritinib Capsules sales, projected growth trends, production technology, application and end-user industry.

Ceritinib Capsules Segment by Company

Novartis

Jiangsu Aosaikang Pharmaceutical

Ceritinib Capsules Segment by Type

150mg

450mg

Ceritinib Capsules Segment by Application

Locally Advanced NSCLC

Metastatic NSCLC

Ceritinib Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceritinib Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ceritinib Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceritinib Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ceritinib Capsules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ceritinib Capsules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ceritinib Capsules sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ceritinib Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 150mg Major Manufacturers Table 3. 450mg Major Manufacturers Table 4. Global Ceritinib Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Locally Advanced NSCLC Major Manufacturers Table 6. Metastatic NSCLC Major Manufacturers Table 7. Ceritinib Capsules Industry Trends Table 8. Ceritinib Capsules Industry Drivers Table 9. Ceritinib Capsules Industry Opportunities and Challenges Table 10. Ceritinib Capsules Industry Restraints Table 11. Global Ceritinib Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Ceritinib Capsules Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Ceritinib Capsules Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Ceritinib Capsules Revenue Market Share by Region (2021-2026) Table 15. Global Ceritinib Capsules Revenue Market Share by Region (2027-2032) Table 16. Global Ceritinib Capsules Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Ceritinib Capsules Sales by Region (2021-2026) & (K Units) Table 18. Global Ceritinib Capsules Sales by Region (2027-2032) & (K Units) Table 19. Global Ceritinib Capsules Sales Market Share by Region (2021-2026) Table 20. Global Ceritinib Capsules Sales Market Share by Region (2027-2032) Table 21. Global Ceritinib Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Ceritinib Capsules Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Ceritinib Capsules Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Ceritinib Capsules Sales Market Share by Manufacturers (2021-2026) Table 25. Global Ceritinib Capsules Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Ceritinib Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Ceritinib Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Ceritinib Capsules Manufacturers, Product Type & Application Table 29. Global Ceritinib Capsules Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Ceritinib Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Ceritinib Capsules Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Ceritinib Capsules Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Ceritinib Capsules Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Ceritinib Capsules Revenue Market Share by Type (2021-2026) Table 36. Global Ceritinib Capsules Revenue Market Share by Type (2027-2032) Table 37. Global Ceritinib Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Ceritinib Capsules Sales by Type (2021-2026) & (K Units) Table 39. Global Ceritinib Capsules Sales by Type (2027-2032) & (K Units) Table 40. Global Ceritinib Capsules Sales Market Share by Type (2021-2026) Table 41. Global Ceritinib Capsules Sales Market Share by Type (2027-2032) Table 42. Global Ceritinib Capsules Price by Type (2021-2026) & (US$/Unit) Table 43. Global Ceritinib Capsules Price by Type (2027-2032) & (US$/Unit) Table 44. Global Ceritinib Capsules Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Ceritinib Capsules Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Ceritinib Capsules Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Ceritinib Capsules Revenue Market Share by Application (2021-2026) Table 48. Global Ceritinib Capsules Revenue Market Share by Application (2027-2032) Table 49. Global Ceritinib Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Ceritinib Capsules Sales by Application (2021-2026) & (K Units) Table 51. Global Ceritinib Capsules Sales by Application (2027-2032) & (K Units) Table 52. Global Ceritinib Capsules Sales Market Share by Application (2021-2026) Table 53. Global Ceritinib Capsules Sales Market Share by Application (2027-2032) Table 54. Global Ceritinib Capsules Price by Application (2021-2026) & (US$/Unit) Table 55. Global Ceritinib Capsules Price by Application (2027-2032) & (US$/Unit) Table 56. Novartis Company Information Table 57. Novartis Business Overview Table 58. Novartis Ceritinib Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Novartis Ceritinib Capsules Product Portfolio Table 60. Novartis Recent Development Table 61. Jiangsu Aosaikang Pharmaceutical Company Information Table 62. Jiangsu Aosaikang Pharmaceutical Business Overview Table 63. Jiangsu Aosaikang Pharmaceutical Ceritinib Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Jiangsu Aosaikang Pharmaceutical Ceritinib Capsules Product Portfolio Table 65. Jiangsu Aosaikang Pharmaceutical Recent Development Table 66. North America Ceritinib Capsules Revenue by Type (2021-2026) & (US$ Million) Table 67. North America Ceritinib Capsules Revenue by Type (2027-2032) & (US$ Million) Table 68. North America Ceritinib Capsules Sales by Type (2021-2026) & (K Units) Table 69. North America Ceritinib Capsules Sales by Type (2027-2032) & (K Units) Table 70. North America Ceritinib Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 71. North America Ceritinib Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 72. North America Ceritinib Capsules Revenue by Application (2021-2026) & (US$ Million) Table 73. North America Ceritinib Capsules Revenue by Application (2027-2032) & (US$ Million) Table 74. North America Ceritinib Capsules Sales by Application (2021-2026) & (K Units) Table 75. North America Ceritinib Capsules Sales by Application (2027-2032) & (K Units) Table 76. North America Ceritinib Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 77. North America Ceritinib Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 78. North America Ceritinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. North America Ceritinib Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 80. North America Ceritinib Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 81. North America Ceritinib Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 82. North America Ceritinib Capsules Sales by Country (2021-2026) & (K Units) Table 83. North America Ceritinib Capsules Sales by Country (2027-2032) & (K Units) Table 84. North America Ceritinib Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 85. North America Ceritinib Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 86. United States Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 87. Canada Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 88. Mexico Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 89. Europe Ceritinib Capsules Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe Ceritinib Capsules Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe Ceritinib Capsules Sales by Type (2021-2026) & (K Units) Table 92. Europe Ceritinib Capsules Sales by Type (2027-2032) & (K Units) Table 93. Europe Ceritinib Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 94. Europe Ceritinib Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 95. Europe Ceritinib Capsules Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Ceritinib Capsules Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Ceritinib Capsules Sales by Application (2021-2026) & (K Units) Table 98. Europe Ceritinib Capsules Sales by Application (2027-2032) & (K Units) Table 99. Europe Ceritinib Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 100. Europe Ceritinib Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 101. Europe Ceritinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Ceritinib Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 103. Europe Ceritinib Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 104. Europe Ceritinib Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 105. Europe Ceritinib Capsules Sales by Country (2021-2026) & (K Units) Table 106. Europe Ceritinib Capsules Sales by Country (2027-2032) & (K Units) Table 107. Europe Ceritinib Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 108. Europe Ceritinib Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 109. Germany Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 110. France Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 111. U.K. Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 112. Italy Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 113. Russia Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 114. Spain Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 115. Netherlands Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 116. Switzerland Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 117. Sweden Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 118. Poland Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 119. China Ceritinib Capsules Revenue by Type (2021-2026) & (US$ Million) Table 120. China Ceritinib Capsules Revenue by Type (2027-2032) & (US$ Million) Table 121. China Ceritinib Capsules Sales by Type (2021-2026) & (K Units) Table 122. China Ceritinib Capsules Sales by Type (2027-2032) & (K Units) Table 123. China Ceritinib Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 124. China Ceritinib Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 125. China Ceritinib Capsules Revenue by Application (2021-2026) & (US$ Million) Table 126. China Ceritinib Capsules Revenue by Application (2027-2032) & (US$ Million) Table 127. China Ceritinib Capsules Sales by Application (2021-2026) & (K Units) Table 128. China Ceritinib Capsules Sales by Application (2027-2032) & (K Units) Table 129. China Ceritinib Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 130. China Ceritinib Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 131. Asia Ceritinib Capsules Revenue by Type (2021-2026) & (US$ Million) Table 132. Asia Ceritinib Capsules Revenue by Type (2027-2032) & (US$ Million) Table 133. Asia Ceritinib Capsules Sales by Type (2021-2026) & (K Units) Table 134. Asia Ceritinib Capsules Sales by Type (2027-2032) & (K Units) Table 135. Asia Ceritinib Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 136. Asia Ceritinib Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 137. Asia Ceritinib Capsules Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia Ceritinib Capsules Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Ceritinib Capsules Sales by Application (2021-2026) & (K Units) Table 140. Asia Ceritinib Capsules Sales by Application (2027-2032) & (K Units) Table 141. Asia Ceritinib Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 142. Asia Ceritinib Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Asia Ceritinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Ceritinib Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Asia Ceritinib Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Asia Ceritinib Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 147. Asia Ceritinib Capsules Sales by Country (2021-2026) & (K Units) Table 148. Asia Ceritinib Capsules Sales by Country (2027-2032) & (K Units) Table 149. Asia Ceritinib Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 150. Asia Ceritinib Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 151. Japan Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 152. South Korea Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 153. India Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 154. Australia Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 155. Taiwan Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 156. Southeast Asia Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 157. SAMEA Ceritinib Capsules Revenue by Type (2021-2026) & (US$ Million) Table 158. SAMEA Ceritinib Capsules Revenue by Type (2027-2032) & (US$ Million) Table 159. SAMEA Ceritinib Capsules Sales by Type (2021-2026) & (K Units) Table 160. SAMEA Ceritinib Capsules Sales by Type (2027-2032) & (K Units) Table 161. SAMEA Ceritinib Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 162. SAMEA Ceritinib Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 163. SAMEA Ceritinib Capsules Revenue by Application (2021-2026) & (US$ Million) Table 164. SAMEA Ceritinib Capsules Revenue by Application (2027-2032) & (US$ Million) Table 165. SAMEA Ceritinib Capsules Sales by Application (2021-2026) & (K Units) Table 166. SAMEA Ceritinib Capsules Sales by Application (2027-2032) & (K Units) Table 167. SAMEA Ceritinib Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 168. SAMEA Ceritinib Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 169. SAMEA Ceritinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. SAMEA Ceritinib Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. SAMEA Ceritinib Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. SAMEA Ceritinib Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 173. SAMEA Ceritinib Capsules Sales by Country (2021-2026) & (K Units) Table 174. SAMEA Ceritinib Capsules Sales by Country (2027-2032) & (K Units) Table 175. SAMEA Ceritinib Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 176. SAMEA Ceritinib Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Brazil Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 178. Argentina Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 179. Chile Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 180. Colombia Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 181. Peru Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 182. Saudi Arabia Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 183. Israel Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 184. UAE Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 185. Turkey Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 186. Iran Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 187. Egypt Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Ceritinib Capsules Distributors List Table 191. Ceritinib Capsules Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Ceritinib Capsules Image Figure 2. Global Ceritinib Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ceritinib Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 4. 150mg Image Figure 5. 450mg Image Figure 6. Global Ceritinib Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ceritinib Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 8. Locally Advanced NSCLC Image Figure 9. Metastatic NSCLC Image Figure 10. Global Ceritinib Capsules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Ceritinib Capsules Revenue (2021-2032) & (US$ Million) Figure 12. Global Ceritinib Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Ceritinib Capsules Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Ceritinib Capsules Revenue Market Share by Region (2021-2032) Figure 15. Global Ceritinib Capsules Sales (2021-2032) & (K Units) Figure 16. Global Ceritinib Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Ceritinib Capsules Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Ceritinib Capsules Sales YoY (2021-2032) & (K Units) Figure 19. Europe Ceritinib Capsules Sales YoY (2021-2032) & (K Units) Figure 20. China Ceritinib Capsules Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Ceritinib Capsules Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Ceritinib Capsules Sales YoY (2021-2032) & (K Units) Figure 23. Global Ceritinib Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Ceritinib Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Ceritinib Capsules Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Ceritinib Capsules Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Ceritinib Capsules Revenue Market Share by Type (2021-2032) Figure 29. Global Ceritinib Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Ceritinib Capsules Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Ceritinib Capsules Sales Market Share by Type (2021-2032) Figure 32. Global Ceritinib Capsules Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Ceritinib Capsules Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Ceritinib Capsules Revenue Market Share by Application (2021-2032) Figure 35. Global Ceritinib Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Ceritinib Capsules Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Ceritinib Capsules Sales Market Share by Application (2021-2032) Figure 38. North America Ceritinib Capsules Revenue Share by Type (2021-2032) Figure 39. North America Ceritinib Capsules Sales Share by Type (2021-2032) Figure 40. North America Ceritinib Capsules Revenue Share by Application (2021-2032) Figure 41. North America Ceritinib Capsules Sales Share by Application (2021-2032) Figure 42. North America Ceritinib Capsules Revenue Share by Country (2021-2032) Figure 43. North America Ceritinib Capsules Sales Share by Country (2021-2032) Figure 44. Europe Ceritinib Capsules Revenue Share by Type (2021-2032) Figure 45. Europe Ceritinib Capsules Sales Share by Type (2021-2032) Figure 46. Europe Ceritinib Capsules Revenue Share by Application (2021-2032) Figure 47. Europe Ceritinib Capsules Sales Share by Application (2021-2032) Figure 48. Europe Ceritinib Capsules Revenue Share by Country (2021-2032) Figure 49. Europe Ceritinib Capsules Sales Share by Country (2021-2032) Figure 50. China Ceritinib Capsules Revenue Share by Type (2021-2032) Figure 51. China Ceritinib Capsules Sales Share by Type (2021-2032) Figure 52. China Ceritinib Capsules Revenue Share by Application (2021-2032) Figure 53. China Ceritinib Capsules Sales Share by Application (2021-2032) Figure 54. Asia Ceritinib Capsules Revenue Share by Type (2021-2032) Figure 55. Asia Ceritinib Capsules Sales Share by Type (2021-2032) Figure 56. Asia Ceritinib Capsules Revenue Share by Application (2021-2032) Figure 57. Asia Ceritinib Capsules Sales Share by Application (2021-2032) Figure 58. Asia Ceritinib Capsules Revenue Share by Country (2021-2032) Figure 59. Asia Ceritinib Capsules Sales Share by Country (2021-2032) Figure 60. SAMEA Ceritinib Capsules Revenue Share by Type (2021-2032) Figure 61. SAMEA Ceritinib Capsules Sales Share by Type (2021-2032) Figure 62. SAMEA Ceritinib Capsules Revenue Share by Application (2021-2032) Figure 63. SAMEA Ceritinib Capsules Sales Share by Application (2021-2032) Figure 64. SAMEA Ceritinib Capsules Revenue Share by Country (2021-2032) Figure 65. SAMEA Ceritinib Capsules Sales Share by Country (2021-2032) Figure 66. Ceritinib Capsules Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Ceritinib Capsules Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 150mg
  • 450mg
Applications
  • Locally Advanced NSCLC
  • Metastatic NSCLC
Companies covered
  • Novartis
  • Jiangsu Aosaikang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ceritinib Capsules Market by Type
  3. 1.2.1 Global Ceritinib Capsules Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 150mg
  5. 1.2.3 450mg
  6. 1.3 Ceritinib Capsules Market by Application
  7. 1.3.1 Global Ceritinib Capsules Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Locally Advanced NSCLC
  9. 1.3.3 Metastatic NSCLC
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Ceritinib Capsules Market Dynamics
  1. 2.1 Ceritinib Capsules Industry Trends
  2. 2.2 Ceritinib Capsules Industry Drivers
  3. 2.3 Ceritinib Capsules Industry Opportunities and Challenges
  4. 2.4 Ceritinib Capsules Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ceritinib Capsules Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ceritinib Capsules Revenue by Region
  3. 3.2.1 Global Ceritinib Capsules Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ceritinib Capsules Revenue by Region (2021-2026)
  5. 3.2.3 Global Ceritinib Capsules Revenue by Region (2027-2032)
  6. 3.2.4 Global Ceritinib Capsules Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ceritinib Capsules Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ceritinib Capsules Sales by Region
  9. 3.4.1 Global Ceritinib Capsules Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ceritinib Capsules Sales by Region (2021-2026)
  11. 3.4.3 Global Ceritinib Capsules Sales by Region (2027-2032)
  12. 3.4.4 Global Ceritinib Capsules Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ceritinib Capsules Revenue by Manufacturers
  2. 4.1.1 Global Ceritinib Capsules Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ceritinib Capsules Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ceritinib Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ceritinib Capsules Sales by Manufacturers
  6. 4.2.1 Global Ceritinib Capsules Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ceritinib Capsules Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ceritinib Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ceritinib Capsules Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ceritinib Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ceritinib Capsules Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ceritinib Capsules Manufacturers, Product Type & Application
  13. 4.7 Global Ceritinib Capsules Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ceritinib Capsules Market CR5 and HHI
  16. 4.8.2 2025 Ceritinib Capsules Tier 1, Tier 2, and Tier 3
5 Ceritinib Capsules Market by Type
  1. 5.1 Global Ceritinib Capsules Revenue by Type
  2. 5.1.1 Global Ceritinib Capsules Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ceritinib Capsules Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ceritinib Capsules Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ceritinib Capsules Sales by Type
  6. 5.2.1 Global Ceritinib Capsules Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ceritinib Capsules Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Ceritinib Capsules Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ceritinib Capsules Price by Type
6 Ceritinib Capsules Market by Application
  1. 6.1 Global Ceritinib Capsules Revenue by Application
  2. 6.1.1 Global Ceritinib Capsules Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ceritinib Capsules Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ceritinib Capsules Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ceritinib Capsules Sales by Application
  6. 6.2.1 Global Ceritinib Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ceritinib Capsules Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Ceritinib Capsules Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ceritinib Capsules Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Ceritinib Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Ceritinib Capsules Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Jiangsu Aosaikang Pharmaceutical
  8. 7.2.1 Jiangsu Aosaikang Pharmaceutical Company Information
  9. 7.2.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  10. 7.2.3 Jiangsu Aosaikang Pharmaceutical Ceritinib Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Jiangsu Aosaikang Pharmaceutical Ceritinib Capsules Product Portfolio
  12. 7.2.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Ceritinib Capsules Market Size by Type
  2. 8.1.1 North America Ceritinib Capsules Revenue by Type (2021-2032)
  3. 8.1.2 North America Ceritinib Capsules Sales by Type (2021-2032)
  4. 8.1.3 North America Ceritinib Capsules Price by Type (2021-2032)
  5. 8.2 North America Ceritinib Capsules Market Size by Application
  6. 8.2.1 North America Ceritinib Capsules Revenue by Application (2021-2032)
  7. 8.2.2 North America Ceritinib Capsules Sales by Application (2021-2032)
  8. 8.2.3 North America Ceritinib Capsules Price by Application (2021-2032)
  9. 8.3 North America Ceritinib Capsules Market Size by Country
  10. 8.3.1 North America Ceritinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ceritinib Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ceritinib Capsules Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Ceritinib Capsules Market Size by Type
  2. 9.1.1 Europe Ceritinib Capsules Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ceritinib Capsules Sales by Type (2021-2032)
  4. 9.1.3 Europe Ceritinib Capsules Price by Type (2021-2032)
  5. 9.2 Europe Ceritinib Capsules Market Size by Application
  6. 9.2.1 Europe Ceritinib Capsules Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ceritinib Capsules Sales by Application (2021-2032)
  8. 9.2.3 Europe Ceritinib Capsules Price by Application (2021-2032)
  9. 9.3 Europe Ceritinib Capsules Market Size by Country
  10. 9.3.1 Europe Ceritinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ceritinib Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ceritinib Capsules Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Ceritinib Capsules Market Size by Type
  2. 10.1.1 China Ceritinib Capsules Revenue by Type (2021-2032)
  3. 10.1.2 China Ceritinib Capsules Sales by Type (2021-2032)
  4. 10.1.3 China Ceritinib Capsules Price by Type (2021-2032)
  5. 10.2 China Ceritinib Capsules Market Size by Application
  6. 10.2.1 China Ceritinib Capsules Revenue by Application (2021-2032)
  7. 10.2.2 China Ceritinib Capsules Sales by Application (2021-2032)
  8. 10.2.3 China Ceritinib Capsules Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ceritinib Capsules Market Size by Type
  2. 11.1.1 Asia Ceritinib Capsules Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ceritinib Capsules Sales by Type (2021-2032)
  4. 11.1.3 Asia Ceritinib Capsules Price by Type (2021-2032)
  5. 11.2 Asia Ceritinib Capsules Market Size by Application
  6. 11.2.1 Asia Ceritinib Capsules Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ceritinib Capsules Sales by Application (2021-2032)
  8. 11.2.3 Asia Ceritinib Capsules Price by Application (2021-2032)
  9. 11.3 Asia Ceritinib Capsules Market Size by Country
  10. 11.3.1 Asia Ceritinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ceritinib Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ceritinib Capsules Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ceritinib Capsules Market Size by Type
  2. 12.1.1 SAMEA Ceritinib Capsules Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ceritinib Capsules Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ceritinib Capsules Price by Type (2021-2032)
  5. 12.2 SAMEA Ceritinib Capsules Market Size by Application
  6. 12.2.1 SAMEA Ceritinib Capsules Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ceritinib Capsules Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ceritinib Capsules Price by Application (2021-2032)
  9. 12.3 SAMEA Ceritinib Capsules Market Size by Country
  10. 12.3.1 SAMEA Ceritinib Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ceritinib Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ceritinib Capsules Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ceritinib Capsules Value Chain Analysis
  2. 13.1.1 Ceritinib Capsules Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ceritinib Capsules Production Mode & Process
  6. 13.2 Ceritinib Capsules Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ceritinib Capsules Distributors
  9. 13.2.3 Ceritinib Capsules Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research